Alpha Cognition, Inc.
Alpha Cognition Inc. is a biopharmaceutical company focused on developing treatments for neurodegenerative diseases like Alzheimer's and ALS.
/10
Transparency ranking
Work at Alpha Cognition, Inc.?
Tell us what we're missing about working at Alpha Cognition, Inc. so we can make the job search more transparent for everyone.
Tell us what it's like to work at Alpha Cognition, Inc.!Description
Alpha Cognition, Inc. (ACI) is a biopharmaceutical company dedicated to developing treatments for neurodegenerative diseases such as Alzheimer's disease and Cognitive Impairment with mild Traumatic Brain Injury (mTBI). The company's flagship product, ZUNVEYL® (benzgalantamine), is a cholinesterase inhibitor approved by the FDA for the treatment of mild to moderate Alzheimer's disease in adults. ACI's development pipeline includes additional programs focused on Alzheimer's disease, including a combination therapy with memantine for moderate-to-severe Alzheimer's, and an intranasal formulation of ZUNVEYL® for the treatment of mTBI.
ACI also has several pre-clinical programs in development for neurodegenerative diseases such as ALS. These programs focus on the potential therapeutic benefits of Progranulin and Granulin Epithelin Motifs (GEMs). The company is committed to finding innovative treatments for patients suffering from neurodegenerative diseases and is actively seeking out-licensing and in-licensing opportunities to accelerate the development and commercialization of its pipeline.
Mission
Alpha Cognition, Inc. is a biopharmaceutical company dedicated to developing novel treatments for patients suffering from neurodegenerative diseases, particularly Alzheimer's disease, Cognitive Impairment with mild Traumatic Brain Injury (mTBI), Amyotrophic Lateral Sclerosis (ALS), and Spinal Muscular Atrophy (SMA). Their mission is to address the significant unmet needs of patients suffering from these debilitating disorders by creating innovative therapies that offer improved efficacy and tolerability compared to existing treatments.
Culture
Alpha Cognition, Inc. promotes a culture of innovation, collaboration, and a shared commitment to improving the lives of patients suffering from neurodegenerative diseases. The company website highlights the passion and expertise of its leadership team, as well as its Scientific Advisory Board, demonstrating a strong emphasis on scientific rigor and a dedication to developing transformative treatments.
Similar companies. But verified.
